Endocrinology

1. Maintaining obesity across adulthood, gaining weight from young to middle adulthood, and losing weight from middle to late adulthood, are all associated with...

1. Early combination therapy with vildagliptin and metformin is associated with improved glycemic durability in the setting of newly diagnosed type 2 diabetes.Evidence Rating...

1. In this large, longitudinal cohort study from the United States, patients with poor health status were more likely to continue insulin use compared...

1. In this population-based cohort study, consumption of total, sugar-, and artificially-sweetened soft drinks was linked with an increased risk of all-cause mortality.2. The...

Intensive glycemic control has been shown to reduce the risk of retinopathy and nephropathy in the setting of type 1 diabetes. While prior studies...

1. Over a median period of almost 16 months, type 2 diabetic (T2DM) patients randomized to oral semaglutide for experienced a similar rate of...

Type 1 diabetes (T1D) is thought to result from a combination of genetic and environmental factors. An increased intake of dietary fiber and gluten...

Preterm birth is the leading cause of infant mortality and neonatal morbidity. Maternal obesity is associated with an increased risk of gestational diabetes and...

1. In relatives of patients with type 1 diabetes (T1DM) at risk for disease development, randomization to teplizumab delayed time to T1DM diagnosis compared...

1. In children with type 2 diabetes (T2DM) on metformin, those randomized to liraglutide had better glycemic control after 26 weeks compared to placebo...